Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

Clinical trial NCT05168813 · COMPLETED

Trial details

NCT number: NCT05168813
Sponsor: COVID-19 Prevention Network
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection HIV Infections COVID-19

Start date: 2021-12-01
Primary completion: 2024-04-19
Enrollment: 14237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.